{"id":914024,"date":"2025-11-26T08:11:30","date_gmt":"2025-11-26T13:11:30","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/"},"modified":"2025-11-26T08:11:30","modified_gmt":"2025-11-26T13:11:30","slug":"whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/","title":{"rendered":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">MORRISTOWN, N.J.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 26, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC)\u00a0cancer treatments, today announced that Dave\u00a0Lennon, PhD, President and CEO,\u00a0will participate in a fireside discussion at the\u00a0Piper Sandler 37th Annual Healthcare Conference in <span class=\"xn-location\">New York City<\/span>, NY on <span class=\"xn-chron\">December 3, 2025<\/span>, at <span class=\"xn-chron\">12:30 PM ET<\/span>.<\/p>\n<p>A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4567044-1&amp;h=3905847934&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4100255-1%26h%3D2471710764%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3955997-1%2526h%253D1403846191%2526u%253Dhttps%25253A%25252F%25252Fir.aadibio.com%25252Fevent-calendar%2526a%253Dwebsite%26a%3Dwebsite&amp;a=website\" target=\"_blank\" rel=\"nofollow\">website<\/a>\u00a0and will be available for replay for approximately 30 days following the event.<\/p>\n<p>\n        <b>About Whitehawk Therapeutics <br \/><\/b><br \/>\n        <span>Whitehawk<\/span><br \/>\n        <span> Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. <\/span>Whitehawk&#8217;s<span> advanced three-asset <\/span>ADC<span> portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from <\/span>WuXi<span> Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at <\/span><a href=\"http:\/\/www.whitehawktx.com\" rel=\"nofollow\">www.whitehawktx.com<\/a><span> and connect with us on LinkedIn.<\/span><\/p>\n<p>\n        <b>Contact:<br \/><\/b><br \/>\n        <a href=\"mailto:IR@whitehawktx.com\" rel=\"nofollow\">IR@whitehawktx.com<\/a>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2929\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg\" title=\"Whitehawk Therapeutics, Inc. logo (PRNewsfoto\/Whitehawk Therapeutics, Inc.)\" alt=\"Whitehawk Therapeutics, Inc. logo (PRNewsfoto\/Whitehawk Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LA33572&amp;sd=2025-11-26\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html<\/a><\/p>\n<p>SOURCE  Whitehawk Therapeutics, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA33572&amp;Transmission_Id=202511260800PR_NEWS_USPR_____LA33572&amp;DateId=20251126\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire MORRISTOWN, N.J. , Nov. 26, 2025 \/PRNewswire\/ &#8212; Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC)\u00a0cancer treatments, today announced that Dave\u00a0Lennon, PhD, President and CEO,\u00a0will participate in a fireside discussion at the\u00a0Piper Sandler 37th Annual Healthcare Conference in New York City, NY on December 3, 2025, at 12:30 PM ET. A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR\u00a0website\u00a0and will be available for replay for approximately 30 days following the event. About Whitehawk Therapeutics Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-914024","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MORRISTOWN, N.J. , Nov. 26, 2025 \/PRNewswire\/ &#8212; Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC)\u00a0cancer treatments, today announced that Dave\u00a0Lennon, PhD, President and CEO,\u00a0will participate in a fireside discussion at the\u00a0Piper Sandler 37th Annual Healthcare Conference in New York City, NY on December 3, 2025, at 12:30 PM ET. A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR\u00a0website\u00a0and will be available for replay for approximately 30 days following the event. About Whitehawk Therapeutics Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk&#8217;s &hellip; Continue reading &quot;Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T13:11:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference\",\"datePublished\":\"2025-11-26T13:11:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"wordCount\":209,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2644441\\\/Whitehawk_Therapeutics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/\",\"name\":\"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2644441\\\/Whitehawk_Therapeutics_Logo.jpg\",\"datePublished\":\"2025-11-26T13:11:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2644441\\\/Whitehawk_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2644441\\\/Whitehawk_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","og_description":"PR Newswire MORRISTOWN, N.J. , Nov. 26, 2025 \/PRNewswire\/ &#8212; Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC)\u00a0cancer treatments, today announced that Dave\u00a0Lennon, PhD, President and CEO,\u00a0will participate in a fireside discussion at the\u00a0Piper Sandler 37th Annual Healthcare Conference in New York City, NY on December 3, 2025, at 12:30 PM ET. A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR\u00a0website\u00a0and will be available for replay for approximately 30 days following the event. About Whitehawk Therapeutics Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk&#8217;s &hellip; Continue reading \"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-26T13:11:30+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference","datePublished":"2025-11-26T13:11:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/"},"wordCount":209,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/","name":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg","datePublished":"2025-11-26T13:11:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2644441\/Whitehawk_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=914024"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914024\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=914024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=914024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=914024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}